Myeloproliferative Neoplasms

Top Story

Is telemedicine a viable option for the treatment of patients with hematologic malignancies?

Is telemedicine a viable option for the treatment of patients with hematologic malignancies?
HemOnc Today, May 10, 2018
Cover Story

Shift from hospital to home would require ‘quantum change’ for care of hematologic malignancies

HemOnc Today, May 10, 2018
Home-based care is the most traditional form of health care. For patients with cancer, providing care at home can improve quality of life, reduce costs and alleviate…
Commentary

Prognostication in myelofibrosis: Integrating genetics into routine practice

HemOnc Today, April 25, 2018
Gabriela Hobbs, MD
One of the most exciting aspects of clinical research is translating lab-based discoveries into tests and treatments that can be used in daily clinical practice. The…
In the Journals PlusPerspective

Hypomethylating agents alone show poor long-term OS for high-risk myelodysplastic syndrome

April 10, 2018
Hypomethylating agents azacitidine and decitabine appeared associated with a 5-year OS probability rate of 4% among patients with myelodysplastic syndrome with…
More Headlines »
CME ABIM MOC

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman…
More »
Video
Meeting News Coverage

VIDEO: PERSIST-2 offers more insight into risk–benefit ratio of pacritinib for myelofibrosis

December 25, 2016
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center

CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »